Treatment of giardiasis

Clinical Microbiology Reviews

Volumn 14, Issue 1, 2001, Pages 114-128

  Gardner, T B ^a   Hill, D R ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACITRACIN ZINC; BENZIMIDAZOLE DERIVATIVE; FURAZOLIDONE; MEPACRINE; NITROIMIDAZOLE DERIVATIVE; PAROMOMYCIN;

ANTIPROTOZOAL ACTIVITY; GIARDIA LAMBLIA; GIARDIASIS; HUMAN; INFECTION RESISTANCE; NONHUMAN; PREGNANCY COMPLICATION; RELAPSE; REVIEW;

ANIMALS; ANTIPROTOZOAL AGENTS; BACITRACIN; BENZIMIDAZOLES; FECES; FEMALE; FURAZOLIDONE; GIARDIA; GIARDIASIS; HUMANS; LACTATION; MALE; MICROSCOPY, ELECTRON, SCANNING; NITROIMIDAZOLES; PAROMOMYCIN; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; QUINACRINE; TIME FACTORS; TREATMENT OUTCOME;

GIARDIA INTESTINALIS; PROTOZOA;

EID: 0035138082     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.14.1.114-128.2001     Document Type: Review

References (266)

1. Epidemiology of giardiasis in Wisconsin: Increasing incidence of reported cases and unexplained seasonal trend
2. Treatment of children with asymptomatic and nondiarrheal Giardia infection
3. Management of giardiasis by an immuno-modulatory herbal drug Pippali rasayana
4. Comparison of nine commercially available enzyme-linked immunosorbent assays for the detection of Giardia lamblia in fecal specimens
5. Therapeutic use of mebendazole in giardial infections
6. Mebendazole in giardial infections: A comparative study with metronidazole
7. American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk
8. Outbreak of giardiasis: Effect of a new antiflagellate drug, tinidazole
9. Chemotherapy of Entamoeba histolytica: Studies in vitro with bacitracin and its zinc salt
10. In vitro sensitivity of Trichomonas vaginalis, Tritrichomonas foetus and Giardia intestinalis to bacitracin and its zinc salt
11. Chemotherapy for giardiasis: Randomized clinical trial of bacitracin, bacitracin zinc, and a combination of bacitracin zinc with neomycin
12. Aminosidine sulphate in experimental giardiasis
13. How does tinidazole compare with metronidazole? A summary of reports of Indian trials in amoebiasis and giardiasis
14. Controlled trial of Giardia lamblia: Control strategies in day care centers
15. Treatment of intestinal E. histolytica and G. lamblia with metronidazole, tinidazole, and ornidazole: A comparative study
16. The treatment of Giardia lamblia infection with mepacrine, metronidazole and furazolidone
17. Giardia lamblia: In-vitro sensitivity to some chemotherapeutic agents
18. Surveillance for foodborne-disease outbreaks - United States, 1988-1992. CDC Surveillance Summaries, October 25, 1996
19. Cancer after exposure to metronidazole
20. Lack of evidence for cancer due to use of metronidazole
21. Structure-activity relationships of pentamidine analogs against Giardia lamblia and correlation of antigiardial activity with DNA-binding affinity
22. Metronidazole and pregnancy
23. Giardia excystation can be induced in vitro in acidic solutions
24. Giardiasis in day-care centers: Evidence of person-to-person transmission
25. Altered uptake of metronidazole in vitro by stocks of Giardia intestinalis with different drug sensitivities
26. A comparison of the in-vitro activity of some 5-nitroimidazoles and other compounds against Giardia intestinalis
27. Heterogeneity in the responses of clones to Giardia intestinalis to anti-giardial drugs
28. The sensitivity of Giardia intestinalis to drugs in vitro
29. The activity of azithromycin against stocks of Giardia intestinalis in vitro and in vivo
30. Metronidazole: Mammalian mutagenicity
31. Reference deleted
32. Metronidazole
33. Giardiasis in American travelers to the Soviet Union
34. 2O-producing NADH oxidase from the protozoan parasite Giardia duodenalis
35. Alternative treatment protocols in giardiasis: A pilot study
36. Zoonotic potential of giardiasis in domestic ruminants
37. Intestinal protozoa and epithelial kinetics, structure and function
38. Safety of metronidazole in pregnancy: A meta-analysis
39. Phenotypic and genotypic variation in Giardia lamblia isolates during chronic infection
40. Efficacia sinergica dell'associaziore albendazole-metronidazolo nella giardiasi refrattaria a monoterapia con metronidazolo
41. Geranins A and B, new antiprotozoal A-type proanthocyanidins from Geranium nivem
42. Genotypic heterogeneity within Giardia lamblia isolates demonstrated by M13 DNA fingerprinting
43. Effects of paromomycin sulfate in man against Entamoeba histolytica and other intestinal protozoa
44. Giardia lamblia: In vitro cytopathic effect of human isolates
45. A comparative study of secnidazole and metronidazole in the treatment of giardiasis
46. New insights into human cryptosporidiosis
47. Triton-labile antigens in flagella isolated from Giardia lamblia
48. Furazolidone and quinacrine. Comparative study of therapy for giardiasis in children
49. Waterborne giardiasis in the United States 1965-1984
50. Waterborne outbreaks of giardiasis: Current status
51. Effect of twenty-three chemotherapeutic agents on the adherence and growth of Giardia lamblia in vitro
52. Sensitivity in vitro of Giardia intestinalis to dyadic combinations of azithromycin, doxycycline, mefloquine, tinidazole and furazolidone
53. Traitement de la giardiase (lambliase) par le métronidazole
54. Issues in clinical parasitology: The treatment of giardiasis
55. Viability of Giardia cysts suspended in lake, river, and tap water
56. Exogenous cytokines released by spleen and Peyer's patch cells removed from mice infected with Giardia muris
57. The discovery of the intestinal protozoa of man
58. El uso de la paromomicina en amebiasis y giardiasis intestinalis
59. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa
60. Histopathology in giardiasis: A correlation with diarrhea
61. Persistent diarrhea in travelers
62. Systemic treatment of human trichomoniasis with a derivative of nitroimidazole
63. A randomised multicentre study to compare the safety and efficacy of albendazole and metronidazole in the treatment of giardiasis in children
64. Susceptibility of Giardia lamblia to aminoglycoside protein synthesis inhibitors: Correlation with rRNA structure
65. Tetracyclines as antiparasitic agents: Lipophilic derivatives are highly active against Giardia lamblia in vitro
66. Activity of the anthelminthic benzimidazoles against Giardia intestinalis in vitro
67. Nitroimidazole drugs - Action and resistance mechanisms. I. Mechanisms of action
68. Furazolidone-induced mood disorder during the treatment of refractory giardiasis in a patient with AIDS
69. Cross-species transmission of Giardia spp.: Inoculation of beavers and muskrats with cysts of human, beaver, mouse, and muskrat origin
70. Formation of the Giardia cyst wall: Studies on extracellular assembly using immunogold labeling and high resolution field emission SEM
71. An examination of differences in serum antibody specificities and hypersensitivity reactions as contributing factors to chronic infection with the intestinal protozoan parasite, Giardia muris, in mice
72. Comparison of genetic groups determined by molecular and immunological analyses of Giardia isolated from animals and humans in Switzerland and Australia
73. Late incidence of cancer after metronidazole use: A matched metronidazole user/nonuser study
74. In vitro drug susceptibility of 29 isolates of Giardia intestinalis from humans as assessed by an adhesion assay
75. Giardia comes of age: Progress in epidemiology, immunology and chemotherapy
76. Giardiasis
77. The molecular pathogenesis of giardiasis
78. Antigiardial activity of the bile salt-like solution antibiotic sodium fusidate
79. Effect of D-propranolol on growth and motility of flagellate protozoa
80. Natural history of Giardia infection of infants and children in rural Guatemala and its impact on physical growth
81. Immune response to Giardia duodenalis
82. Detection of Giardia lamblia and Cryptosporidium parvum antigens in human fecal specimens using the ColorPac combination rapid solid-phase qualitative immunochromatographic assay
83. Evaluation of nine immunoassay kits (enzyme immunoassay and direct fluorescence) for detection of Giardia lamblia and Cryptosporidium parvum in human fecal specimens
84. Furazolidone and metronidazole in the treatment of giardiasis
85. Mebendazole and metronidazole in giardial infections
86. Single dose therapy of giardiasis with tinidazole and metronidazole
87. Inhibition of clonal growth of Giardia lamblia and Entamoeba histolytica by metronidazole, quinacrine and other antimicrobial agents
88. Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis
89. Rapid reinfection by Giardia lamblia after treatment in a hyperendemic Third World community
90. The relative merits of faecal and duodenal juice microscopy in the diagnosis of giardiasis
91. Metronidazole
92. Understanding intestinal spore-forming protozoa: Cryptosporidia, microsporidia, isospora, and cyclospora
93. Estudio comparativo en amebiasis y giardiasis intestinal del lactante y pre-escolar: Eficacia y tolerancia del secnidazol vs metronidazol y etofamida
94. In vitro susceptibilities of 25 Giardia lamblia isolates of human origin to six commonly used antiprotozoal agents
95. Effect of periodic antiascaris and antigiardia treatment on nutritional status of preschool children
96. Albendazole as a treatment for infections with Giardia duodenalis in children in Bangladesh
97. Giardiasis and its treatment
98. Giardiasis: Clinical spectrum and functional-structural abnormalities of the small intestinal mucosa
99. Chronische Giardiasis mit intestinalem Kleinwuchs and Pubertas tarda bei Immunoglobulinmangelsyndrom: Vollstandiges Aufholwachstum nach Therapie
100. Cellular and transcriptional changes during excystation of Giardia lamblia in vitro
101. Immunology of Giardia and Cryptosporidium infections
102. How many stool examinations are necessary to detect pathogenic intestinal protozoa?
103. Giardia lamblia
104. Giardiasis: Issues in management and treatment
105. Susceptibility of Giardia lamblia trophozoites to the lethal effect of human serum
106. Intestinal flagellate and ciliate infections
107. Giardia lamblia: A culture method for determining parasite viability
108. A radiometric assay for antigiardial drugs
109. Epidemic and endemic seroprevalence of antibodies to Cryptosporidium and Giardia in residents of three communities with different drinking water supplies
110. A second community outbreak of waterborne giardiasis in Canada and serological investigation of patients
111. Comparison of an in vitro method and an in vivo method of Giardia excystation
112. Asymptomatic giardiasis in children
113. Effect of chlorine on Giardia lamblia cyst viability
114. Outbreak of giardiasis associated with mains water in the United Kingdom
115. Anti-giardial activity of gastrointestinal remedies of the Luo of east Africa
116. Prospective study of acquisition of cryptosporidium, Giardia lamblia, and gastrointestinal illness
117. Comparative evaluation of two dosages of tinidazole in the treatment of giardiasis
118. Comparison of four dosage schedules in the treatment of giardiasis with metronidazole
119. Giardiasis in travelers: A prospective study
120. In vitro susceptibility of Giardia lamblia to metronidazole and tinidazole
121. Single-dose metronidazole and tinidazole as therapy for giardiasis: Success rates, side effects, and drug absorption and elimination
122. Treatment of giardiasis: Comparative evaluation of ornidazole and tinidazole as a single oral dose
123. Comparison of mebendazole with metronidazole and furazolidone in the treatment of giardiasis in children
124. A novel and simple colorimetric method for screening Giardia intestinalis and anti-giardial activity in vitro
125. Sensitive and rapid detection of viable Giardia cysts and Cryptosporidium parvum oocysts in large-volume water samples with wound fiberglass cartridge filters and reverse transcription-PCR
126. Giardiasis in infancy and childhood: A prospective study of 160 cases with comparison of quinacrine (Atabrine®) and metronidazole (Flagyl®)
127. Giardia lamblia infection in a group of students after a visit to Leningrad in March 1970
128. Albendazole is highly effective against cutaneous larva migrans but not against Giardia infection: Results of an open pilot trial in travellers returning from the tropics
129. Routine in vitro cultivation of Giardia lamblia by using the string test
130. Surveillance for waterborne-disease outbreaks - United States, 1993-1994. CDC Surveillance Summaries, April 12, 1996
131. Giardiasis in pregnancy
132. Bacitracin and gramicidin
133. Neomycin, framycetin and paromomycin
134. Nitrofurans: Nitrofurozone, furazolidone and nitrofurantoin
135. Central nervous system toxicity associated with metronidazole therapy
136. Observations of the efficacy of ornidazole (Tiberal La Roche) in treatment of giardiasis
137. Treatment of giardiasis: Relative efficacy of metronidazole as compared with tinidazole
138. Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives
139. Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome
140. Severe giardiasis in the United States
141. Treatment of giardiasis. Literature review and recommendations
142. Efficacy of various drugs for treatment of giardiasis. A comparative study
143. Foodborne disease outbreaks in nursing homes, 1975 through 1987
144. Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles
145. Induction of albendazole resistance in Giardia lamblia
146. Antiparasitic drugs
147. Mechanisms of Giardia lamblia differentiation into cysts
148. Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine
149. Detection of Giardia in environmental waters by immuno-PCR amplification methods
150. Risk factors for development of first symptomatic Giardia infection among infants of a birth cohort in rural Egypt
151. Heterogeneity in the sensitivity of stocks and clones of Giardia to metronidazole and ornidazole
152. Sensitivity of microscopy versus enzyme immunoassay in the laboratory diagnosis of giardiasis
153. Intestinal protozoa in homosexual men of the San Francisco Bay area: Prevalence and correlates of infection
154. Chemotherapy in giardiasis: Clinical responses and in vitro drug sensitivity of human isolates in axenic culture
155. Flagyl
156. Furoxone
157. Intestinal and urogenital flagellates
158. Albendazole: A more effective antigiardial agent in vitro than metronidazole or tinidazole
159. Giardia and giardiasis
160. Giardia lamblia infection in homosexual men
161. Foodborne giardiasis in a corporate office setting
162. Age-related rate of seropositivity of antibody to Giardia lamblia in four diverse populations
163. A comparative trial of albendazole versus metronidazole in children with giardiasis
164. Ensayo terapeutica con un preparado a base de propoleo "propolisina" en la giardiasis del humano
165. Molecular genetic analysis of Giardia intestinalis isolates at the glutamate dehydrogenase locus
166. Epidemic giardiasis at a ski resort
167. Activities of several benzimidazoles and tubulin inhibitors against Giardia spp. in vitro
168. Protection against infection with Giardia lamblia by breast feeding in a cohort of Mexican infants
169. Mode of action of metronidazole on anaerobic bacteria and protozoa
170. Five vs. ten days' therapy with furazolidone for giardiasis
171. The effect of metronidazole and quinacrine on the morphology and the excystation of Giardia lamblia
172. Efficacies of zinc-finger-active drugs against Giardia lamblia
173. Antigenic variation in Giardia lamblia and the host's immune response
174. Experimental human infections with Giardia lamblia
175. Treatment of refractory giardiasis
176. Specific secretory IgA in the milk of Giardia lamblia-infected and uninfected women
177. Giardiasis and vitamin B12 malabsorption
178. Giardiasis: A histologic analysis of 567 cases
179. Single-dose ornidazole versus seven-day metronidazole therapy of giardiasis in Kibbutzim children in Israel
180. An outbreak of foodborne giardiasis
181. Respiration in the cysts and trophozoites of Giardia muris
182. Giardia lamblia groups A and B among young adults in India
183. Ensayo terapéutico con cinco medicamentos en lambliasis
184. A comparison of two methods for assessing drug sensitivity in Giardia duodenalis
185. Albendazole treatment of Giardia intestinalis infections in school children
186. Occurrence of Giardia lamblia in children in day care centers
187. Transmission of Giardia lamblia from a day care center to the community
188. Propranolol and metronidazole for the treatment of metronidazole-resistant giardiasis
189. Albendazole as a treatment for Giardia infection
190. Restaurant-associated outbreak of giardiasis
191. The polymicrobial origin of intestinal infections in homosexual men
192. Furazolidone and metronidazole for treatment of giardiasis in children
193. Longitudinal study of Giardia lamblia infection in a day care center population
194. Human milk kills Giardia lamblia by generating toxic lipolytic products
195. Diarrhea in returning Austrian tourists: Epidemiology, etiology, and cost-analysis
196. The experimental transmission of human intestinal protozoan parasites. II. Giardia lamblia cysts given in capsules
197. Efficacy of albendazole against Giardia and hookworm in a remote Aboriginal community in the north of Western Australia
198. Albendazole as a future antigiardial agent
199. The mode of action of benzimidazoles against Giardia and their chemotherapeutic potential against Giardia and other parasitic protozoa
200. Improved in vitro excystation procedure for Giardia lamblia cysts
201. Eficacia y seguridad de mebendazol contra nitazoxanida en el tratamiento de Giardia lamblia en niños
202. Safety of nitroimidazoles
203. Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico
204. Estudio aleatorio para comparar seguridad y eficacia de albendazol y metronidazol en el tratamiento de giardiasis en niños
205. Pregnancy outcomes after first-trimester vaginitis drug therapy
206. The primary immunodeficiencies
207. Nitroimidazoles in the treatment of trichomoniasis, giardiasis, and amebiasis
208. Giardiasis and amebiasis in pregnancy
209. An increase in Giardia duodenalis infection among children receiving periodic anthelminthic treatment in Bangladesh
210. Treatment of giardiasis in children with quinacrine, metronidazole, tinidazole and ornidazole
211. Giardia lamblia: Prevalence, influence on growth, and symptomatology in healthy nursery children
212. Symptomatic giardiasis in Sudanese adults and its treatment with tinidazole
213. Why metronidazole is active against both bacteria and parasites
214. Endemic giardiasis and day care
215. Chronic giardiasis: Studies on drug sensitivity, toxin production, and host immune response
216. Gasirointestinal infections in AIDS
217. Giardiasis: Nutritional implications
218. A new method for assessing metronidazole susceptibility of Giardia lamblia trophozoites
219. Single-dose tinidazole for the treatment of giardiasis
220. Recurrent outbreaks of giardiasis in a child care center
221. Illness and reservoirs associated with Giardia lamblia infection in rural Egypt: The case against treatment in developing world environments of high endemicity
222. Treatment of giardiasis in children with tinidazole, ornidazole and metronidazole
223. In vitro inhibition of Giardia lamblia and Trichomonas vaginalis growth by bithionol, dichlorophene, and hexachlorophene
224. Combined metronidazole and quinacrine hydrochloride therapy for chronic giardiasis
225. Determination of Giardia cyst viability in environmental and faecal samples by immunofluorescence, fluorogenic dye staining and differential interference microscopy
226. Giardia and giardiasis
227. Giardia lamblia in children and the child care setting: A review of the literature
228. A purified ferredoxin from Giardia duodenalis
229. Characterization and purification of pyruvate:ferredoxin oxidoreductase from Giardia duodenalis
230. Drugs used in the chemotherapy of protozoal infections
231. Antigiardial and immunostimulatory effect of Piper longum on giardiasis due to Giardia lamblia
232. Giardiasis in mice: Studies on the characteristics of chronic infection in C3H/He mice
233. Albendazole resistance in Giardia is correlated with cytoskeletal changes but not with a mutation at amino acid 200 in beta-tubulin
234. My favorite cell: Giardia
235. Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamoeba spp.
236. Quinacrine-resistant Giardia duodenalis
237. Drug resistance and Giardia
238. Two distinct varieties of Giardia in a mixed infection from a single human patient
239. Drug resistance in Giardia intestinalis
240. Albendazole
241. On the mutagenicity of nitroimidazoles
242. A primitive enzyme for a primitive cell: The protease required for excystation of Giardia
243. Furazolidone in the treatment of giardiasis
244. Giardiasis
245. Giardiasis
246. Giardiasis
247. Evidence for animal reservoirs and transmission of Giardia infection between animal species
248. Guidelines for treatment of cystic and alveolar echinococcosis in humans
249. Epithelial and other mucosal lesions of the jejunum in giardiasis. Jejunal biopsy studies
250. Effect of ivermectin on combined intestinal protozoal infection (giardiasis and cryptosporidiosis)
251. A systematic review on the treatment of giardiasis
252. Comparison of conventional stool concentration and preserved-smear methods with Merifluor Cryptosporidium/Giardia Direct Immunofluorescence Assay and ProSpecT Giardia EZ microplate assay for the detection of Giardia lamblia
253. Distribution of aminoglycoside antibiotics in blood and milk